Best Options Strategy for ALEC
Looking for the best options strategy for Alector, Inc. (ALEC)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live ALEC option chain right now, and a simple map from your view on ALEC to the strategy that fits it. Model any of them in the calculator before you trade.
About ALEC
Alector, Inc. (ALEC) is a major company in Biotechnology. Options traders on ALEC tend to watch , since these can drive large moves in the share price.
About Alector, Inc.
Alector, Inc. is a clinical-stage biotech firm focused on developing treatments for neurodegenerative diseases in the U.S. market. The company's most advanced candidate, Nivisnebart, is a monoclonal antibody currently in clinical testing for multiple neurodegenerative conditions. Beyond that, Alector has a roster of earlier-stage programs: AL137 targets Alzheimer's disease through anti-amyloid beta activity; AL050 is an enzyme replacement approach designed for Parkinson's disease and Lewy body dementia in patients with specific genetic mutations; and several preclinical candidates using RNA interference technology, including programs against tau and alpha-synuclein pathology. Notably, the company partners with GlaxoSmithKline on developing progranulin-elevating antibodies, a collaboration that includes both Latozinemab and Nivisnebart.
Revenue generation remains limited given the company's early development stage. Alector operates primarily through research funding, partnerships, and milestone payments from collaborations rather than product sales. The partnership with GlaxoSmithKline likely provides capital and development support for shared candidates, though the bulk of…
Today's top-scoring strategy for ALEC
Our engine ranks defined-risk strategies on the live ALEC chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 100× | STOCK | — | $2.04 |
| Sell | 1× | CALL | $2.5 | $0.18 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $3 | $39 | $33 | $27 | $22 | $16 |
| $2 | $34 | $29 | $23 | $17 | $12 |
| $2 | $29 | $24 | $18 | $13 | $7 |
| $2 | $23 | $18 | $13 | $8 | $3 |
| $2 | $17 | $12 | $7 | $3 | −$2 |
| $2 | $10 | $6 | $1 | −$3 | −$8 |
| $2 | $2 | −$1 | −$5 | −$10 | −$14 |
| $2 | −$6 | −$9 | −$13 | −$16 | −$20 |
| $2 | −$15 | −$17 | −$20 | −$23 | −$27 |
| $2 | −$24 | −$26 | −$28 | −$31 | −$34 |
| $2 | −$34 | −$35 | −$37 | −$39 | −$42 |
Live scan from 2026-08-14 · quotes delayed ~15 minutes
Historical backtest: how a Covered Call on ALEC would have performed
We approximated a Covered Call on ALEC, entered repeatedly over the past year (92 historical entries, each held to expiration) with Black-Scholes-modelled entry premiums. Here is how that would have played out on real ALEC price history — an educational backtest, not a prediction of future returns.
Approximate: entry premiums are modelled with Black-Scholes from trailing realised volatility, held to expiration and settled against the real historical close. Real fills, implied volatility and slippage differ — treat it as directional context, not exact returns.
Implied volatility
ALEC is currently trading with high implied volatility, which makes its options expensive — and attractive to sell. On the options we scanned that was around 127% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on ALEC currently price in about 127% implied volatility, versus roughly 115% the stock has actually realised over the past month. The two are roughly in line, so neither buying nor selling premium has a clear volatility edge here.
Off that volatility, the options market is pricing a move of about ±$0.79 (±39%) in ALEC by 2026-09-18 — a range of roughly $1.25 to $2.84. Strikes inside that band hold most of the premium and see most of the action.
ALEC insider trading activity (SEC Form 4)
Open-market insider transactions at ALEC over roughly the last six months, from SEC Form 4 filings. Open-market buys are the rarer, more telling signal — routine selling under pre-arranged plans is common, so read a net-selling figure with that in mind.
| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| Wong-Sarad Grace | Sell | 3,475 | $7K | 2026-06-03 |
| Rosenthal Arnon | Sell | 87,216 | $172K | 2026-06-02 |
| Wong-Sarad Grace | Sell | 5,709 | $11K | 2026-06-02 |
| Berkley Neil Lindsay | Sell | 19,360 | $38K | 2026-06-02 |
| Wong-Sarad Grace | Sell | 1,820 | $5K | 2026-04-16 |
| Wong-Sarad Grace | Sell | 1,000 | $3K | 2026-03-10 |
Source: SEC Form 4 filings via Finnhub. Open-market purchases (P) and sales (S) only — grants, option exercises, gifts and tax withholding are excluded. Informational context, not investment advice.
Earnings & IV crush
ALEC's next earnings report is due around November 5, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Key figures
- Market cap
- $165M
- Beta (vs market)
- 0.58
- 52-week range
- $1.09–$3.40 (41% up the range)
- Short interest
- 5.4% of float · 6.2 days to cover
Other strong setups for ALEC
If your view on ALEC differs, these also scored well in the latest scan:
- Poor Man's Covered Call (POP 57%) Experienced
How to choose an options strategy for ALEC
Start with your outlook on ALEC, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while ALEC stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open ALEC in the free calculator →
Frequently asked questions
What is the best options strategy for ALEC?
It depends on your outlook. Bullish traders often use a long call or bull call spread on ALEC; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are ALEC options liquid enough to trade?
Alector, Inc. (ALEC) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade ALEC options?
Buying a single ALEC call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade ALEC or any security. Do your own research.
What does Alector, Inc. do?
Alector, Inc. (ALEC) operates in the Biotechnology industry. The "About Alector, Inc." section above gives a fuller picture of what the company does and how it earns money.
Does Alector, Inc. pay a dividend?
We don't show a confirmed dividend yield for Alector, Inc. here, so treat it as uncertain: before writing calls, check its current dividend and ex-dividend date with your broker — an approaching ex-dividend date can trigger early assignment on in-the-money short calls.
When does Alector, Inc. next report earnings?
Alector, Inc.'s next earnings are expected around November 5, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Tickers related to ALEC
Comparing ALEC with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 131 Oyster Point Boulevard, Suite 600, South San Francisco, CA, 94080, United States
- Industry
- Biotechnology
- Employees
- 103
- CEO
- Dr. Arnon Rosenthal Ph.D.
- Phone
- 415 231 5660
- Website
- www.alector.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.